Labor (Term and Preterm) Is Associated With Changes in the Placental mRNA Expression of Corticotrophin-Releasing Factor

Abstract

Because maternal plasma corticotrophin-releasing factor (CRF) levels increase during the last weeks of pregnancy and at parturition, the present study evaluated whether placental mRNA expression of CRF and CRF-binding protein (CRF-BP) are modified in preterm delivery. A group of 30 women with singleton pregnancies were enrolled in the study. A placental tissue specimen was collected from pregnant women (1) at term after cesarean delivery (39.3 ± 0.1 gestational weeks; n = 10), (2) at term after spontaneous vaginal delivery (40.1 ± 0.2 gestational weeks; n = 10), or (3) at preterm delivery (32.4 ± 0.4 gestational weeks; n = 10). Changes of placental mRNA expression were evaluated by real-time quantitative reverse transcriptase polymerase chain reaction analysis. Placental CRF mRNA expression at term (P < .001) and preterm delivery (P < .001) was significantly higher than in cesarean delivery and highest in preterm placentas. With respect to CRF-BP, no significant difference in placental mRNA expression was observed among samples collected after term or preterm delivery and cesarean delivery. The present study showed for the first time that both term and preterm labor are associated with increased expression of placental CRF but not CRF-BP mRNA.

Keywords

CRF CRF-BP placenta preterm delivery.

Get full access to this article

View all access options for this article.

References

Gibb W. , Challis JR Mechanisms of term and preterm birth. J Obstet Gynaecol Can . 2002;24:874-883.

Liggins GC Adrenocortical-related maturational events in the fetus. Am J Obstet Gynecol. 1976;126:931-941.

Thorburn GD , Challis JR Endocrine control of parturition. Physiol Rev. 1979;59:863-918.

Challis Jrg , Matthews SG , Gibb W. , Lye SJ Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev. 2000;21:514-550.

Florio P. , Cobellis L. , Woodman J. , Severi FM , Linton EA , Petraglia F. Levels of maternal plasma corticotropin-releasing factor and urocortin during labor. J Soc Gynecol Investig. 2002; 9:233-237.

Perkins AV , Linton EA Identification and isolation of corticotrophin-releasing hormone-positive cells from the human placenta. Placenta. 1995 ;16:233-243.

Campbell EA , Linton EA , Wolfe CD , Scraggs PR , Jones MT , Lowry PJ

Plasma corticotrophin-releasing hormone concentrations during pregnancy and parturition

J Clin Endocrinol Metab. 1987;64:1054-1059.

Petraglia F. , Potter E. , Cameron VA , et al. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab. 1993;77:919-924.

Behan DP , De Souza EB , Lowry PJ , Potter E. , Sawchenko P. , Vale WW Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front Neuroendocrinol. 1995;16:362-382.

10.

Blanc WA Pathology of the placenta and cord in ascending and in haematogenous infection . Ciba Found Symp. 1979;77:17-38.

11.

Livak KJ , Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402-408.

12.

McLean M. , Smith R. Corticotropin-releasing hormone in human pregnancy and parturition. Trends Endocrinol Metab. 1999;10:174-178.

13.

Linton EA , Perkins AV , Woods RJ , et al. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J Clin Endocrinol Metab. 1993;76:260-262.

14.

Goland RS , Wardlaw SL , Stark RI , Brown LS Jr, Frantz AG High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab. 1986;63:1199-1203.

15.

Sasaki A. , Tempst P. , Liotta AS , et al. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J Clin Endocrinol Metab. 1988;67:768-773.

16.

Slominski A. , Zbytek B. , Zmijewski M. , et al. Corticotropin releasing hormone and the skin. Front Biosci. 2006;11:2230-2248.

17.

Orth DN Corticotropin-releasing hormone in humans. Endocr Rev. 1992;13:64-91.

18.

Challis Jrg. Mechanism of parturition and preterm labor. Obstet Gynecol Surv. 2000;55:650-660.

19.

Jones SA , Brooks AN , Challis Jrg. Steroids modulate corticotrophin-releasing factor production in human fetal membranes and placenta. J Clin Endocrinol Metab. 1989;68: 825-830.

20.

Petraglia F. , Sutton S. , Vale W. Neurotransmitters and peptides modulate the release of immunoreactive corticotropin-releasing factor from cultured human placental cells. Am J Obstet Gynecol. 1989 ;160:247-251.

21.

Grammatopoulos D. , Stirrat GM , Williams SA , Hillhouse EW The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J Clin Endocrinol Metab. 1996;81:745-751.

22.

Berkowitz GS , Lapinski RH , Lockwood CJ , Florio P. , Blackmore-Prince C. , Petraglia F. Corticotropin-releasing factor and its binding protein: maternal serum levels in term and preterm deliveries. Am J Obstet Gynecol. 1996;174: 1477-1483.

23.

Petraglia F. , Florio P. , Simoncini T. , et al. Cord plasma corticotropin-releasing factor-binding protein (CRF-BP) in term and preterm labour. Placenta. 1997;18:115-119.

24.

Florio P. , Woods RJ , Genazzani AR , Lowry PJ , Petraglia F. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor . J Clin Endocrinol Metab. 1997;82:835-838.

25.

Pati S. , Lee Y. , Samaniego F. Urinary proteins with pro-apoptotic and antitumor activity. Apoptosis. 2000;5:21-28.